Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | metabotropic glutamate receptor | 0.0261 | 0.654 | 0.713 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.133 | 0.145 |
Loa Loa (eye worm) | metabotropic GABA-B receptor subtype 2 | 0.008 | 0.1427 | 0.1427 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.133 | 0.1669 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.133 | 0.145 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.3238 | 0.3238 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.3238 | 0.3238 |
Echinococcus multilocularis | GPCR, family 3, C terminal | 0.0051 | 0.0601 | 0.0601 |
Onchocerca volvulus | Poor gastrulation protein homolog | 0.0051 | 0.0601 | 1 |
Leishmania major | extracellular receptor, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.133 | 0.133 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.133 | 0.133 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0152 | 0.346 | 0.4342 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.133 | 0.145 |
Brugia malayi | Receptor family ligand binding region containing protein | 0.008 | 0.1427 | 0.1792 |
Echinococcus granulosus | GPCR family 3 C terminal | 0.0051 | 0.0601 | 0.0601 |
Loa Loa (eye worm) | glutamate receptor | 0.0312 | 0.7968 | 0.7968 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1427 | 0.1427 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0601 | 0.0601 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0152 | 0.346 | 0.3772 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.133 | 0.145 |
Loa Loa (eye worm) | hypothetical protein | 0.0384 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0601 | 0.0655 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.133 | 0.133 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.133 | 0.133 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.133 | 0.133 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.133 | 0.145 |
Brugia malayi | metabotropic GABA-B receptor subtype 2 | 0.0051 | 0.0601 | 0.0754 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.133 | 0.1669 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0355 | 0.9173 | 1 |
Onchocerca volvulus | Metabotropic glutamate receptor homolog | 0.0051 | 0.0601 | 1 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0312 | 0.7968 | 1 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0283 | 0.7141 | 0.8962 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0384 | 1 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0261 | 0.654 | 0.654 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0261 | 0.654 | 0.654 |
Loa Loa (eye worm) | glutamate receptor | 0.0123 | 0.2633 | 0.2633 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.3238 | 0.4064 |
Brugia malayi | RNA binding protein | 0.0076 | 0.133 | 0.1669 |
Trypanosoma cruzi | extracellular receptor, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.008 | 0.1427 | 0.1427 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.